Dragan Micic

Summary

Publications

  1. ncbi Metformin: its emerging role in oncology
    Dragan Micic
    Institute of Endocrinology, Diabetes and Diseases of Metabolism, University of Belgrade, Serbia
    Hormones (Athens) 10:5-15. 2011
  2. doi Intracerebroventricular administration of metformin inhibits ghrelin-induced Hypothalamic AMP-kinase signalling and food intake
    Darko Stevanovic
    Institute of Medical Physiology, University of Belgrade, Belgrade, Serbia
    Neuroendocrinology 96:24-31. 2012
  3. doi Therapeutic improvement of glucoregulation in newly diagnosed type 2 diabetes patients is associated with a reduction of IL-17 levels
    Mirjana Sumarac-Dumanovic
    Clinic for Endocrinology, Diabetes and Diseases of Metabolism, School of Medicine, University of Belgrade, Dr Subotica 13, Belgrade 11000, Serbia
    Immunobiology 218:1113-8. 2013
  4. doi Inhibition of AMPK-dependent autophagy enhances in vitro antiglioma effect of simvastatin
    Maja Misirkic
    Institute of Microbiology and Immunology, School of Medicine, University of Belgrade, Dr Subotica 1, 11000 Belgrade, Serbia
    Pharmacol Res 65:111-9. 2012
  5. ncbi Ectopic calcitonin secretion in a woman with large cell neuroendocrine lung carcinoma
    Goran Cvijovic
    Clinic for Endocrinology, Diabetes and Diseases of Metabolism, Faculty of Medicine, University of Belgrade, Serbia
    Hormones (Athens) 12:584-90. 2013
  6. ncbi Risk factors clustering within the metabolic syndrome: a pattern or by chance?
    Biljana Parapid
    Faculty of Medicine, University of Belgrade, Belgrade, Serbia
    Hellenic J Cardiol 55:92-100. 2014
  7. ncbi Frax score calculations in postmenopausal women with subclinical hypothyroidism
    Snezana Polovina
    Clinic for Endocrinology, Diabetes and Diseases of Metabolism, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
    Hormones (Athens) 12:439-48. 2013
  8. ncbi Age and body mass related changes of cardiovascular risk factors in women with polycystic ovary syndrome
    Duro Macut
    Institute of Endocrinology, Diabetes and Diseases of Metabolism, University of Belgrade Medical School, Belgrade
    Vojnosanit Pregl 59:593-9. 2002
  9. doi Immunomodulatory actions of central ghrelin in diet-induced energy imbalance
    Darko Stevanovic
    Institute of Medical Physiology, School of Medicine, University of Belgrade, 11000 Belgrade, Serbia
    Brain Behav Immun 26:150-8. 2012
  10. doi In vitro and in vivo anti-melanoma action of metformin
    Kristina Janjetovic
    Institute of Microbiology and Immunology, School of Medicine, University of Belgrade, Dr Subotica 1, 11000 Belgrade, Serbia
    Eur J Pharmacol 668:373-82. 2011

Collaborators

  • Vera Popovic
  • Mirjana Sumarac-Dumanovic
  • Darko Stevanovic
  • Kristina Janjetovic
  • Vladimir Trajkovic
  • Maja Misirkic
  • Ljubica Vucicevic
  • Goran Cvijovic
  • Snezana Polovina
  • Biljana Parapid
  • Danka Jeremić
  • Vesna Starcevic
  • Urosh Vilimanovich
  • Ljubica Harhaji-Trajkovic
  • Aleksandra Kendereski
  • Natasa Milic
  • Svetlana Zoric
  • Jelena Marinkovic
  • Duro Macut
  • Katarina Lalic
  • Svetozar Damjanovic
  • Nebojsa M Lalic
  • Dragana Bubanja
  • Miodrag C Ostojic
  • Natasa M Milic
  • Dragan Simic
  • Aleksandar Pantovic
  • Svetislav Tatic
  • Leonidas Duntas
  • Aleksandar Trivić
  • Danica Stamenkovic-Pejkovic
  • Danica Pejkovic-Stamenkovic
  • Emina Savic
  • Vladimir Bumbasirevic
  • Emina Sudar
  • Dejan Nesić
  • Gordana Tovilovic
  • Biljana Ristic
  • Dusan Popadic
  • Maja Misirkic-Marjanovic
  • Nevena Zogovic
  • Lidija Tulic
  • Azra Muharemagić
  • Mirjana Sumarac
  • Danica Pejkovic

Detail Information

Publications10

  1. ncbi Metformin: its emerging role in oncology
    Dragan Micic
    Institute of Endocrinology, Diabetes and Diseases of Metabolism, University of Belgrade, Serbia
    Hormones (Athens) 10:5-15. 2011
    ..These new encouraging experimental data supporting the anti-cancer effects of metformin urgently require further clinical studies in order to establish its use as a synergistic therapy targeting the AMPK/mTOR signaling pathway...
  2. doi Intracerebroventricular administration of metformin inhibits ghrelin-induced Hypothalamic AMP-kinase signalling and food intake
    Darko Stevanovic
    Institute of Medical Physiology, University of Belgrade, Belgrade, Serbia
    Neuroendocrinology 96:24-31. 2012
    ..The present study investigated the effects of intracerebroventricular administration of metformin on food intake and hypothalamic appetite-regulating signalling pathways induced by the orexigenic peptide ghrelin...
  3. doi Therapeutic improvement of glucoregulation in newly diagnosed type 2 diabetes patients is associated with a reduction of IL-17 levels
    Mirjana Sumarac-Dumanovic
    Clinic for Endocrinology, Diabetes and Diseases of Metabolism, School of Medicine, University of Belgrade, Dr Subotica 13, Belgrade 11000, Serbia
    Immunobiology 218:1113-8. 2013
    ..2 to 12.9 pg/ml, p=0.020), but not IFN-γ (50.6 vs. 52.3, p=0.349). These data indicate that therapeutic improvement of glucoregulation might contribute to a reduction of IL-17 levels in newly diagnosed type 2 diabetes patients...
  4. doi Inhibition of AMPK-dependent autophagy enhances in vitro antiglioma effect of simvastatin
    Maja Misirkic
    Institute of Microbiology and Immunology, School of Medicine, University of Belgrade, Dr Subotica 1, 11000 Belgrade, Serbia
    Pharmacol Res 65:111-9. 2012
    ..These data suggest that inhibition of AMPK-dependent autophagic response might sensitize glioma cells to statin-induced apoptotic death...
  5. ncbi Ectopic calcitonin secretion in a woman with large cell neuroendocrine lung carcinoma
    Goran Cvijovic
    Clinic for Endocrinology, Diabetes and Diseases of Metabolism, Faculty of Medicine, University of Belgrade, Serbia
    Hormones (Athens) 12:584-90. 2013
    ..Serum calcitonin (CT) is a sensitive but not specific marker for medullary thyroid carcinoma (MTC). There are a large number of conditions that may elevate CT levels...
  6. ncbi Risk factors clustering within the metabolic syndrome: a pattern or by chance?
    Biljana Parapid
    Faculty of Medicine, University of Belgrade, Belgrade, Serbia
    Hellenic J Cardiol 55:92-100. 2014
    ..However, it remains unclear whether specific risk factors aggregate following a predefined pattern or whether this happens by chance...
  7. ncbi Frax score calculations in postmenopausal women with subclinical hypothyroidism
    Snezana Polovina
    Clinic for Endocrinology, Diabetes and Diseases of Metabolism, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
    Hormones (Athens) 12:439-48. 2013
    ..The aim of our study was to evaluate the relationship between the elevated TSH and fracture risk in postmenopausal women with subclinical hypothyroidism for evaluation of individuals with a high risk for osteoporotic fractures...
  8. ncbi Age and body mass related changes of cardiovascular risk factors in women with polycystic ovary syndrome
    Duro Macut
    Institute of Endocrinology, Diabetes and Diseases of Metabolism, University of Belgrade Medical School, Belgrade
    Vojnosanit Pregl 59:593-9. 2002
    ....
  9. doi Immunomodulatory actions of central ghrelin in diet-induced energy imbalance
    Darko Stevanovic
    Institute of Medical Physiology, School of Medicine, University of Belgrade, 11000 Belgrade, Serbia
    Brain Behav Immun 26:150-8. 2012
    ..Therefore, central ghrelin may play a complex role in energy imbalance-induced inflammation by modulating HPA axis, leptin and AMPK/ERK signaling pathways...
  10. doi In vitro and in vivo anti-melanoma action of metformin
    Kristina Janjetovic
    Institute of Microbiology and Immunology, School of Medicine, University of Belgrade, Dr Subotica 1, 11000 Belgrade, Serbia
    Eur J Pharmacol 668:373-82. 2011
    ..These data suggest that anti-melanoma effects of metformin are mediated through p21- and AMPK-independent cell cycle arrest, apoptosis and autophagy associated with p53/Bcl-2 modulation, mitochondrial damage and oxidative stress...